Case Study: Ori Biotech achieves improved biological performance through digitized process development with Benchling R&D Cloud

Improving biological performance through digitized process development

Ori Biotech, a London‑based cell and gene therapy company, faced the common CGT challenge of scaling process development while relying on paper, spreadsheets, and disconnected point solutions. Those legacy approaches led to unstructured data capture, limited real‑time visibility, manual errors and slow, labor‑intensive optimization that constrained throughput and consistency.

By adopting a digitally‑native platform built on the Benchling R&D Cloud, Ori standardized and automated data capture, linked assays to donor IDs, ingested instrument data, and created customizable templates for multiple cell types. The result: faster planning and milestone achievement, fewer data‑entry errors, reduced experimental workload, improved biological performance and throughput, and better process consistency and scientist efficiency — enabling lower costs and quicker progress toward scalable CGT manufacturing.

Ori Biotech

Matt Todd

Head of Architecture